急性食管胃底静脉曲张破裂出血行急诊经颈静脉肝内门体分流术后发生肝性脑病的危险因素分析

姚运海; 罗艳; 朱京乐; 甘建和; 赵卫峰

doi:10.3969/j.issn.1001-5256.2020.02.022

急性食管胃底静脉曲张破裂出血行急诊经颈静脉肝内门体分流术后发生肝性脑病的危险因素分析

DOI: 10.3969/j.issn.1001-5256.2020.02.022

1. 苏州大学附属第一医院感染科/肝病ICU
2. 湖南省妇幼保健院医务部

基金项目:

医学科学研究基金(YWJKJJHKJJ-g1706)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 975
- HTML全文浏览量: 59
- PDF下载量: 208
- 被引次数: 0
出版历程
- 收稿日期: 2019-09-18
- 出版日期: 2020-02-20

Risk factors for hepatic encephalopathy after emergency transjugular intrahepatic portosystemic shunt for patients with acute esophagogastric variceal bleeding

Department of Infectious Diseases/Intensive Care Unit of Hepatology,The First Hospital Affiliated of Soochow University

Research funding:

摘要

摘要:
目的通过临床结果分析了解急性食管胃底静脉曲张破裂出血行急诊经颈静脉肝内门体分流术（TIPS）术后肝性脑病（HE）的危险因素。方法回顾性分析2013年1月-2018年12月因失代偿期肝硬化伴急性食管胃底静脉曲张破裂出血在苏州大学附属第一医院接受内镜或者药物治疗失败,72 h内行覆膜支架TIPS治疗的93例患者的临床资料。根据术后发生HE情况分为HE组（n=36）和非HE组（n=57）。收集患者术前临床资料,包括性别、年龄、病因、合并症,血生化指标包括WBC、PLT、红细胞比积、TBil、AST、Alb、血清肌酐、PT等,根据实测值分别计算每位患者MELD评分,记录TIPS支架植入前测得的肝静脉锲压与游离压,肝静脉压力梯度（HVPG）为两者的差值。计量资料两组间比较采用t检验或Mann-Whitney U检验;计数资料两组间比较采用χ2检验。二分类变量logistic回归分析TIPS术后患者的预后危险因素。结果术后HE发病率为38. 710%,两组间术前MELD评分[（13. 000±3. 189）分vs（11. 684±2. 068）分,t=2. 068,P=0. 043]、HVPG[（...
- 食管和胃静脉曲张 /
- 肝性脑病 /
- 危险因素
Abstract:
Objective To investigate the risk factors for hepatic encephalopathy( HE) after emergency transjugular intrahepatic portosystemic shunt( TIPS) for patients with acute esophagogastric variceal bleeding( EVB) based on an analysis of clinical outcomes. Methods A retrospective analysis was performed for the clinical data of 93 patients with decompensated liver cirrhosis and acute EVB who failed endoscopy or medication and then underwent TIPS with a covered stent within 72 hours in The First Affiliated Hospital of Soochow University from January 2013 to December 2018. According to the presence or absence of HE after surgery,they were divided into HE group with 36 patients and non-HE group with 57 patients. Preoperative clinical data were collected,including sex,age,etiology,comorbidities,and blood biochemical parameters [white blood cell count( WBC),platelet count( PLT),hematocrit( Hct),total bilirubin( TBil),aspartate aminotransferase( AST),albumin( Alb),serum creatinine( SCr),and prothrombin time( PT) ],and the measured values were used to calculate Model for End-Stage Liver Disease( MELD) score. Wedged hepatic venous pressure( WHVP) and free hepatic venous pressure( FHVP) were measured and recorded before TIPS stent implantation,and hepatic venous pressure gradient( HVPG) was the difference between WHVP and FHVP. The t-test or the Mann-Whitney U test was used for comparison between two groups,and the chi-square test was used for comparison of categorical data between two groups. A binary logistic regression analysis was used to identify the risk factors for the prognosis of patients after TIPS. Results The incidence rate of postoperative HE was 38. 710%. There were significant differences between the two groups in preoperative MELD score( 13. 000 ± 3. 189 vs 11. 684 ± 2. 068,t = 2. 068,P = 0. 043) and HVPG( 24. 908 ±5. 317 mm Hg vs 22. 597 ± 4. 928 mm Hg,t = 2. 100,P = 0. 039). Based on the results of HE grading,17 patients( 47. 222%) had grade0-1 HE,9( 25. 000%) had grade 2 HE,6( 16. 667%) had grade 3 HE,and 4( 11. 111%) had grade 4 HE. The stepwise logistic regression analysis showed that MELD score( odds ratio [OR]= 0. 803,95% confidence interval [CI]: 0. 679-0. 948,P = 0. 010) and HVPG( OR = 0. 896,95% CI: 0. 816-0. 984,P = 0. 022) were independent risk factors for HE after TIPS. Conclusion There is a high incidence rate of HE after emergency TIPS for acute EVB,and preoperative MELD score and HVPG can predict the risk of HE after TIPS.
- esophageal and gastric varices /
- hepatic encephalopathy /
- risk factors

HTML全文

参考文献(25)

[1] HE FL,WANG L,YUE ZD,et al. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients[J]. World J Gastroenterol,2014,20(33):11835-11839.

[2] YU ZG,LIN YH,HUANG WF,et al. Clinical efficacy and safety of different endoscopy methods in patients with liver cirrhosis complicated with esophagogastric varicosity bleeding[J]. J Clin Exp Med,2018,17(8):813-816.(in Chinese)余中贵，林燕华，黄文峰，等．不同内镜方案对肝硬化合并食管胃底静脉曲张破裂出血患者临床疗效及安全性分析[J]．临床和实验医学杂志，2018,17(8):813-816.

[3] GARCIA-TG,ABRALDES JG,BERZIGOTTI A,et al. Portal hypertensive bleeding in cirrhosis:Risk stratification,diagnosis,and management:2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology,2017,65(1):310-335.

[4] PAPATHEODORIDIS GV,GOULIS J,LEANDRO G,et al. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding:A metaanalysis[J]. Hepatology,1999,30(3):612-622.

[5] Portal hypertension group of Chinese Surgery Branch. Consensus diagnosis and treatment of cirrhotic portal hypertension with esophageal and gastric varices bleeding(2015 edition)[J]. Chin J Gen Surg,2016,31(2):167-170.(in Chinese)中华外科学分会门静脉高压症学组．肝硬化门静脉高压症食管胃底静脉曲张破裂出血的诊治共识(2015版)[J]．中华普通外科杂志，2016,31(2):167-170.

[6] Chinese Society of Hepatology,Chinese Medical Association.Guidelines on the management of hepatic encephalopathy in cirrhosis[J]. J Clin Hepatol,2018,34(10):2076-2089.(in Chinese)中华医学会肝病学分会．肝硬化肝性脑病诊疗指南[J]．临床肝胆病杂志，2018,34(10):2076-2089.

[7] MASSON S,MARDINI HA,ROSE JD,et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion:A decade of experience[J]. QJM,2008,101(6):493-501.

[8] Chinese Portal Hypertension Diagnosis and Monitoring Study Group(CHESS); Minimally Invasive Intervention Collaborative Group,Chinese Society of Gastroenterology; Emergency Intervention Committee,Chinese College of Interventionalists,et al. Consensus on clinical application of hepatic venous pressure gradient in China(2018)[J]. J Clin Hepatol,2018,34(12):2526-2536.(in Chinese)中国门静脉高压诊断与监测研究组(CHESS)，中华医学会消化病学分会微创介入协作组，中国医师协会介入医师分会急诊介入专业委员会，等．中国肝静脉压力梯度临床应用专家共识(2018版)[J]．临床肝胆病杂志，2018,34(12):2526-2536.

[9] LU W,YANG C,ZHANG JC,et al. The effect of wedged hepatic venography with CO2during TIPS in the treatment of acute upper gastro-intestinal bleeding in liver cirrhosis[J].China Med Herald,2019,16(10):84-87.(in Chinese)卢伟，杨超，张嘉诚，等．CO2楔入肝静脉造影在肝硬化急性上消化道出血的TIPS术中的作用[J]．中国医药导报，2019,16(10):84-87.

[10] LYU Y,ZUO L,ZHU X,et al. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding:A multicentre observational study[J]. Gut,2019,68(7):1297-1310.

[11] SIRAMOLPIWAT S. Transjugular intrahepatic portosystemic shunts and portal hypertension related complications[J]. World J Gastroenterol,2014,20(45):16996-17010.

[12] FERENCI P,LOCKWOOD A,MULLEN K,et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification:Final report of the working party at the 11th World Congresses of Gastroenterology[J]. Hepatology,2002,35(3):716-721.

[13] ABRALDES JG,TANDON P. Therapies:Drugs,scopes and transjugular intrahepatic portosystemic shunt--when and how?[J]. Dig Dis,2015,33(4):524-533.

[14] MENDEZ M,MENDEZ-LOPEZ M,LOPEZ L,et al. Portosystemic hepatic encephalopathy model shows reversal learning impairment and dysfunction of neural activity in the prefrontal cortex and regions involved in motivated behavior[J]. J Clin Neurosci,2011,18(5):690-694.

[15] LUO X,ZHAO M,WANG X,et al. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft[J]. PLo S One,2019,14(2):e0212658.

[16] RIGGIO O,NARDELLI S,MOSCUCCI F,et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Clin Liver Dis,2012,16(1):133-146.

[17] PEREIRA K,CARRION AF,MARTIN P,et al. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy[J]. Liver Int,2015,35(12):2487-2494.

[18] AHMED R,SANTHANAM P,RAYYAN Y. MELD-Na as a prognostic indicator of 30-and 90-day mortality in patients with end-stage liver disease after creation of transjugular intrahepatic portosystemic shunt[J]. Eur J Gastroenterol Hepatol,2015,27(10):1226-1227.

[19] LUCIDI C,LATTANZI B,RIGGIO O,et al. May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease?[J]. J Hepatol,2018,68(6):1324-1325.

[20] MALINCHOC M,KAMATH PS,GORDON FD,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology,2000,31(4):864-871.

[21] NARDELLI S,GIOIA S,PASQUALE C,et al. Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Am J Gastroenterol,2016,111(4):523-528.

[22] KIM TY,LEE JG,SOHN JH,et al. Hepatic venous pressure gradient predicts long-term mortality in patients with decompensated cirrhosis[J]. Yonsei Med J,2016,57(1):138-145.

[23] AMESUR NB,NOVELLI P. Transjugular intrahepatic portosystemic shunt[M]. Stat Pearls. Treasure Island(FL):Stat Pearls Publishing,2019.

[24] ZIVON AS,CHEN L,KAUFMAN J,et al. The degree in reduction of portal-systemic gradient during tips and not final post-tips portal pressure gradient is predictive of the development of hepatic encephalopathy[J]. Gastroenterology,2014,1461(5):s932.

[25] CHUNG HH,RAZAVI MK,SZE DY,et al. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft:What is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?[J]. J Gastroenterol Hepatol,2008,23(1):95-101.

施引文献

资源附件(0)

访问统计